ANI Pharmaceuticals, Inc. (ANIP) stock prices updated...
 

ANI Pharmaceuticals, Inc. stock price

ANI Pharmaceuticals, Inc. latest news:


  • 01/08/2018 09:41:17

    Health-care ETF tumbles as biotechnology stocks weigh

    The largest exchange-traded fund to track the health-care sector fell on Monday, dropping as the biggest declining industry of the day by far. The Health Care Select Sector SPDR ETF was down 0.8%, its biggest one-day percentage drop since Dec. 14. The fund is coming off a four-day rally, and it hit a record on Friday. Biotechnology companies were the biggest drags on the sector on Monday. Celgene Corp. fell 3.2% after it agreed to buy blood-disease biotechnology company Impact Biomedicines for as much as $7 billion. Separately, Biogen Inc. shares fell 3.9% while those for Regeneron Pharmaceuticals was down 3.1%. The iShares Nasdaq Biotechnology ETF fell 0.8% on Monday. Thus far this year, the health-care fund is up 2.3%, compared with the 2.6% rise of the S&P 500 . The S&P was unchanged in Monday trading.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/15/2017 13:03:45

    Pennsylvania man admits to trading on tips about drug company

    Dec 15 (Reuters) - A Pennsylvania man pleaded guilty on Friday to charges that he traded on confidential, inside information that a former Celator Pharmaceuticals Inc employee supplied him, including that the company now owned by Jazz Pharmaceuticals Plc was planning to be acquired.

  • 12/04/2017 14:19:51

    BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017

    Sunesis Pharmaceuticals Inc(SNSS): * Sunesis Pharmaceuticals Inc(SNSS) - DANIEL SWISHER RESIGNS AS CEO EFFECTIVE END OF 2017. * Sunesis Pharmaceuticals Inc (SNSS) - SWISHER TO REMAIN WITH SUNESIS AS A STRATEGIC ADVISOR. * Sunesis Pharmaceuticals Inc (SNSS) - BOARD MEMBER DAYTON MISFELDT APPOINTED INTERIM CEO EFFECTIVE JANUARY 2018 Source text for Eikon: Further company coverage:

  • 11/16/2017 12:06:35

    LPC: US loan issuers lean on bond market to refinance parts of jumbo loans

    US companies with rocky histories in the leveraged loan market, including vitamin and supplement retailer GNC Holdings Inc (GNC), weight loss company Weight Watchers International (WTW) and specialty drug maker Valeant Pharmaceuticals International, are turning to the high-yield bond market to help refinance large existing loans, sources said.

  • 11/13/2017 06:04:12

    Teva's stock drops after J.P. Morgan downgrades to rare bearish rating

    Shares of Teva Pharmaceutical Industries Ltd. shed 2.2% in premarket trade Monday, after the generic drug maker was downgraded at J.P. Morgan to a rare bearish rating, citing concerns over the U.S. generics business and growing debt levels. Analyst Chris Schott cut his rating to underweight, after being at neutral the past 10 months. Only 6% of companies covered by J.P. Morgan analysts have an underweight rating. "While admittedly Teva shares have been under pressure (down 68% in 2017 and 16% since 3Q results), we see an extended road to recovery and no clear fundamental inflection in sight given ongoing challenges in the company's U.S. generics business (which we do not see growing until 2019), Copaxone generic competition, and growing levels of leverage (>5x in 2018 based on our estimates). Last week, Fitch Ratings downgraded Teva's credit rating in "junk" territory. Teva's stock has underperformed its peers and the broader market by a wide margin, as the SPDR S&P Pharmaceuticals ETF has gained 5.7% year to date and the S&P 500 has climbed 15%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/09/2017 09:36:42

    Apellis Pharma, Sogou enjoy gains in their trading debut

    The latest two companies to make their trading debut this week were enjoying initial stock gains Thursday. Apellis Pharmaceuticals Inc. , a clinical-stage biotech, was trading up 1.4% after pricing at the midpoint of their range. The company sold 10.7 million shares to raise about $150 million. Apellis shares are trading on Nasdaq under the ticker symbol "APLS". Separately, Chinese search engine Sogou Inc. saw its shares gain 5% in early trade. The company priced its IPO at $13 a share, the top end of its $11 to $13 range. The company sold 45 million shares to raise $585 million. Shares are listed on the New York Stock Exchange under the ticker symbol "SOGO". The S&P 500 was last down 0.5%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Anika Therapeutics Inc.ANIK | ANSYS, Inc.ANSS | Antares Pharma, Inc.ATRS | Anthera Pharmaceuticals, Inc.ANTH | Aoxin Tianli Group, Inc.ABAC | API Technologies Corp.ATNY | Apigee CorporationAPIC | Apogee Enterprises, Inc.APOG | Apollo Education Group, Inc.APOL | Apollo Investment CorporationAINV |